Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2008-05-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training
NCT00075283
Robot-Assisted Gait Therapy in the Subacute Phase of First Ischemic Stroke
NCT04910217
Gait Training for Persons With Stroke
NCT00612300
Gait Recovery in Patients After Acute Ischemic Stroke
NCT04824482
Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training
NCT00037895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lokomat Intervention
Lokomat gait training (five days a week for eight weeks for a total of 40 sessions).
Lokomat
Robotic-assisted walking device
Standard of Care
Conventional physical therapy focusing on gait training for five days a week for eight weeks for a total of 40 sessions.
Physical Therapy
Conventional physical therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical Therapy
Conventional physical therapy
Lokomat
Robotic-assisted walking device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age\>18
* At least 3 months post stroke at time of enrollment into study
* Ability to walk at least 10 feet with maximum 1 person assist, but not to walk in the community independently
* Residual paresis in the lower extremity as defined by the National Institute of Health Stroke Scale lower extremity motor score 2-4
* Ability to perform Lokomat ambulation training with assistance of 1 therapist
* Ability to follow a three-step command
* Physician approval for patient participation
* Ability to give informed consent
* Completed their rehabilitation services, i.e., receiving no concurrent physical, occupational, or speech therapies
Exclusion Criteria
* Uncontrolled blood pressure, defined as \> 200 or diastolic \> 100 at rest
* Hx of serious chronic obstructive pulmonary disease or oxygen dependence
* Sever weight bearing pain
* Lower extremity amputation
* Claudication while walking
* Life expectancy \< 1 year
* History of deep vein thrombosis/pulmonary embolism (DVT/PE) within 6 months
* Severe orthopedic problem
* Any medical or psychiatric condition that the investigators believe would make the patient unable to participate in this study
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elizabeth Noser
Clinical Assistant Professor - Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Noser, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Hermann
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Medallion Grant
Identifier Type: -
Identifier Source: secondary_id
HSC-MH-08-0206
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.